The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Drugs for Enuresis Market Research Report 2024

Global Drugs for Enuresis Market Research Report 2024

Publishing Date : Sep, 2023

License Type :
 

Report Code : 1725276

No of Pages : 90

Synopsis
The drugs used to treat enuresis are mainly stimulants of central nervous system or antidiuretic hormones
Global Drugs for Enuresis market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drugs for Enuresis market research.
Key manufacturers engaged in the Drugs for Enuresis industry include Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp and Mallinckrodt, Inc., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Drugs for Enuresis were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Drugs for Enuresis market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Drugs for Enuresis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Allergan
Ferring Pharmaceuticals, Inc.
Pfizer Inc.
Janssen Pharmaceuticals, Inc.
Urovant Sciences, Inc.
Astellas Pharma US, Inc.
Bayer Corp
Mallinckrodt, Inc.
Segment by Type
Anticholinergic Drugs
Tricyclic Antidepressants
Desmopressin
Segment by Application
Hospital
Specialist Clinic
Othere
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Drugs for Enuresis report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Drugs for Enuresis Market Overview
1.1 Product Overview and Scope of Drugs for Enuresis
1.2 Drugs for Enuresis Segment by Type
1.2.1 Global Drugs for Enuresis Market Value Comparison by Type (2023-2029)
1.2.2 Anticholinergic Drugs
1.2.3 Tricyclic Antidepressants
1.2.4 Desmopressin
1.3 Drugs for Enuresis Segment by Application
1.3.1 Global Drugs for Enuresis Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Othere
1.4 Global Drugs for Enuresis Market Size Estimates and Forecasts
1.4.1 Global Drugs for Enuresis Revenue 2018-2029
1.4.2 Global Drugs for Enuresis Sales 2018-2029
1.4.3 Global Drugs for Enuresis Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Drugs for Enuresis Market Competition by Manufacturers
2.1 Global Drugs for Enuresis Sales Market Share by Manufacturers (2018-2023)
2.2 Global Drugs for Enuresis Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Drugs for Enuresis Average Price by Manufacturers (2018-2023)
2.4 Global Drugs for Enuresis Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Drugs for Enuresis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drugs for Enuresis, Product Type & Application
2.7 Drugs for Enuresis Market Competitive Situation and Trends
2.7.1 Drugs for Enuresis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drugs for Enuresis Players Market Share by Revenue
2.7.3 Global Drugs for Enuresis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drugs for Enuresis Retrospective Market Scenario by Region
3.1 Global Drugs for Enuresis Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Drugs for Enuresis Global Drugs for Enuresis Sales by Region: 2018-2029
3.2.1 Global Drugs for Enuresis Sales by Region: 2018-2023
3.2.2 Global Drugs for Enuresis Sales by Region: 2024-2029
3.3 Global Drugs for Enuresis Global Drugs for Enuresis Revenue by Region: 2018-2029
3.3.1 Global Drugs for Enuresis Revenue by Region: 2018-2023
3.3.2 Global Drugs for Enuresis Revenue by Region: 2024-2029
3.4 North America Drugs for Enuresis Market Facts & Figures by Country
3.4.1 North America Drugs for Enuresis Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Drugs for Enuresis Sales by Country (2018-2029)
3.4.3 North America Drugs for Enuresis Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drugs for Enuresis Market Facts & Figures by Country
3.5.1 Europe Drugs for Enuresis Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Drugs for Enuresis Sales by Country (2018-2029)
3.5.3 Europe Drugs for Enuresis Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs for Enuresis Market Facts & Figures by Country
3.6.1 Asia Pacific Drugs for Enuresis Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Drugs for Enuresis Sales by Country (2018-2029)
3.6.3 Asia Pacific Drugs for Enuresis Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drugs for Enuresis Market Facts & Figures by Country
3.7.1 Latin America Drugs for Enuresis Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Drugs for Enuresis Sales by Country (2018-2029)
3.7.3 Latin America Drugs for Enuresis Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs for Enuresis Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs for Enuresis Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Drugs for Enuresis Sales by Country (2018-2029)
3.8.3 Middle East and Africa Drugs for Enuresis Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drugs for Enuresis Sales by Type (2018-2029)
4.1.1 Global Drugs for Enuresis Sales by Type (2018-2023)
4.1.2 Global Drugs for Enuresis Sales by Type (2024-2029)
4.1.3 Global Drugs for Enuresis Sales Market Share by Type (2018-2029)
4.2 Global Drugs for Enuresis Revenue by Type (2018-2029)
4.2.1 Global Drugs for Enuresis Revenue by Type (2018-2023)
4.2.2 Global Drugs for Enuresis Revenue by Type (2024-2029)
4.2.3 Global Drugs for Enuresis Revenue Market Share by Type (2018-2029)
4.3 Global Drugs for Enuresis Price by Type (2018-2029)
5 Segment by Application
5.1 Global Drugs for Enuresis Sales by Application (2018-2029)
5.1.1 Global Drugs for Enuresis Sales by Application (2018-2023)
5.1.2 Global Drugs for Enuresis Sales by Application (2024-2029)
5.1.3 Global Drugs for Enuresis Sales Market Share by Application (2018-2029)
5.2 Global Drugs for Enuresis Revenue by Application (2018-2029)
5.2.1 Global Drugs for Enuresis Revenue by Application (2018-2023)
5.2.2 Global Drugs for Enuresis Revenue by Application (2024-2029)
5.2.3 Global Drugs for Enuresis Revenue Market Share by Application (2018-2029)
5.3 Global Drugs for Enuresis Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Drugs for Enuresis Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Allergan Drugs for Enuresis Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Ferring Pharmaceuticals, Inc.
6.2.1 Ferring Pharmaceuticals, Inc. Corporation Information
6.2.2 Ferring Pharmaceuticals, Inc. Description and Business Overview
6.2.3 Ferring Pharmaceuticals, Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ferring Pharmaceuticals, Inc. Drugs for Enuresis Product Portfolio
6.2.5 Ferring Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Corporation Information
6.3.2 Pfizer Inc. Description and Business Overview
6.3.3 Pfizer Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Inc. Drugs for Enuresis Product Portfolio
6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Janssen Pharmaceuticals, Inc.
6.4.1 Janssen Pharmaceuticals, Inc. Corporation Information
6.4.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
6.4.3 Janssen Pharmaceuticals, Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Janssen Pharmaceuticals, Inc. Drugs for Enuresis Product Portfolio
6.4.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
6.5 Urovant Sciences, Inc.
6.5.1 Urovant Sciences, Inc. Corporation Information
6.5.2 Urovant Sciences, Inc. Description and Business Overview
6.5.3 Urovant Sciences, Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Urovant Sciences, Inc. Drugs for Enuresis Product Portfolio
6.5.5 Urovant Sciences, Inc. Recent Developments/Updates
6.6 Astellas Pharma US, Inc.
6.6.1 Astellas Pharma US, Inc. Corporation Information
6.6.2 Astellas Pharma US, Inc. Description and Business Overview
6.6.3 Astellas Pharma US, Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Astellas Pharma US, Inc. Drugs for Enuresis Product Portfolio
6.6.5 Astellas Pharma US, Inc. Recent Developments/Updates
6.7 Bayer Corp
6.6.1 Bayer Corp Corporation Information
6.6.2 Bayer Corp Description and Business Overview
6.6.3 Bayer Corp Drugs for Enuresis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer Corp Drugs for Enuresis Product Portfolio
6.7.5 Bayer Corp Recent Developments/Updates
6.8 Mallinckrodt, Inc.
6.8.1 Mallinckrodt, Inc. Corporation Information
6.8.2 Mallinckrodt, Inc. Description and Business Overview
6.8.3 Mallinckrodt, Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mallinckrodt, Inc. Drugs for Enuresis Product Portfolio
6.8.5 Mallinckrodt, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs for Enuresis Industry Chain Analysis
7.2 Drugs for Enuresis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs for Enuresis Production Mode & Process
7.4 Drugs for Enuresis Sales and Marketing
7.4.1 Drugs for Enuresis Sales Channels
7.4.2 Drugs for Enuresis Distributors
7.5 Drugs for Enuresis Customers
8 Drugs for Enuresis Market Dynamics
8.1 Drugs for Enuresis Industry Trends
8.2 Drugs for Enuresis Market Drivers
8.3 Drugs for Enuresis Market Challenges
8.4 Drugs for Enuresis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’